0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Long-term results of autologous plasma as adjuvant to pars plana vitrectomy in the treatment of high myopic full-thickness macular holes.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To analyse the feasibility and efficacy of a novel autologous plasma rich in growth factor (PRGF) preparation as adjuvant to pars plana vitrectomy and internal limiting membrane peel in high myopic full-thickness macular hole (FTMH).

          Related collections

          Author and article information

          Journal
          Eur J Ophthalmol
          European journal of ophthalmology
          SAGE Publications
          1724-6016
          1120-6721
          Sep 2021
          : 31
          : 5
          Affiliations
          [1 ] Retina Division, Ophthalmology Department, Ramon y Cajal University Hospital, Madrid, Spain.
          [2 ] Alcala University, Madrid, Spain.
          [3 ] Vissum, Madrid, Spain.
          [4 ] Ophthalmology Department, Careggi University Hospital, University of Florence, Firenze, Italy.
          [5 ] Ophthalmology Department, Fatebenefratelli-Oftalmico Hospital, ASST Fatebenefratelli-Sacco, Milan, Italy.
          [6 ] Vitreoretinal Division, Bristol Eye Hospital, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
          Article
          10.1177/1120672120960340
          32985261
          4738c6de-fd66-4924-ae49-80d1d33a72d3
          History

          Pars plana vitrectomy,macular hole,pathologic myopia,retina,vitreous traction syndromes,vitreous/endophthalmitis,epiretinal membrane

          Comments

          Comment on this article